About this trial
Nearly one in ten people who are hospitalized in Canada develop a complication with sudden loss of kidney function, called acute kidney injury (AKI). AKI may lead to other severe health problems after discharge home, such as kidney failure requiring dialysis treatment, heart failure, heart attacks, stroke, and even premature death. Discharge from hospital to home can be a difficult transition where there are often gaps in identification, communication, care coordination, education, and planning of care for AKI. The study team will co-design and evaluate a tailored post-discharge care plan that is based on the risk of later kidney problems and uses currently available, yet untapped digital innovation to improve the health and experience of people with AKI.
This study will be built into Alberta's new Epic Systems based provincial electronic health record (EHR). The plan is to use digital tools in the EHR to identify all people in Alberta hospitals that have had an AKI event and are at increased risk of long-term complications. Half will randomly be assigned to receive a tailored care plan based on their risk at hospital discharge while the other half will receive care as it is currently provided by their healthcare team. The electronic health system will automatically calculate a patient's risk and report this risk in their chart along with recommendations for care. The study team includes patients, healthcare providers, and health system decision makers needed to co-develop the proposed strategy and introduce the changes needed to deliver this intervention. The investigators will study whether this strategy can reduce health problems that may happen after AKI including death, chronic kidney disease (CKD), kidney failure, heart attacks, and stroke. The investigators will also determine if the approach improves patient experience during the transition from hospital to home. This study has the potential to revolutionize how we care for people that leave hospital after having AKI.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥ 18 years old
Hospitalized at site using AHS EHR
Acute Kidney Injury (Stage 1-3) identified in hospital per KDIGO guideline criteria
Disqualifiers
Pre-hospitalization advanced CKD: eGFR<30 mL/min/1.73m2
Pre-hospitalization dialysis
Very low risk (<1% risk) of advanced CKD
Non-Alberta resident
Trial design
Parallel
Treatments tested in this trial
Risk-guided transition of care intervention delivered through an integrated digital health strategy
Other interventionPatients will receive transition of care plans that are tailored to their medical profile and risk and embedded within standardized discharge pathways within the EHR- Education and self-management guidance about AKI for patients, Medication guidance based on evidence-based indications for reducing risk of cardiac and kidney outcomes, Recommendations for subsequent laboratory testing of kidney function, proteinuria and electrolytes according to clinical characteristics and risks, Recommendations for timing and nature of PCP follow-up, Information about the patient's AKI and subsequent management provided to PCPs through discharge summary, Recommendations for outpatient Pharmacy follow-up for medication reconciliation and review according to patient risk and medication management gaps, Recommendations for Nephrology referral for high risk patients
Treatment groups
Trial outcomes
Primary outcomes
Primary effectiveness outcome
The primary outcome of the study is major adverse kidney or CV events within 2 years after discharge, defined as the composite of death, kidney failure (receipt of maintenance dialysis, kidney transplant or eGFR \< 15 mL/min/1.73m2 for 4 weeks or more), or hospitalization with a most responsible diagnosis for heart failure, myocardial infarction, or stroke (based on validated ICD-10 coding algorithms)
Secondary outcomes
Secondary Clinical Outcomes-Death
Death from any cause within 2 years of discharge
Safety Outcomes- Hyperkalemia
Serum potassium ≥ 6.0 mEq/L on outpatient lab testing within one year of discharge
Safety Outcomes-Hospitalization for Kidney Disease Ambulatory Care Specific Condition
Hospitalization for a Kidney Disease Ambulatory Care Specific Condition (Congestive Heart Failure, Volume Overload, Hyperkalemia, or Hypertensive Emergency) within one year after discharge (based on ICD-10 coding algorithms)
Safety Outcomes-All Cause Hospitalization or ED Visit
All-cause hospitalization or ED visits within 30 and 90 days of discharge
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Alberta
Lead sponsor
Alberta Health services
Collaborator
Canadian Institutes of Health Research (CIHR)
Collaborator
University of Calgary
Collaborator